New mapping tech could make heart ablation more precise
NCT ID NCT07320560
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a non-invasive global mapping system can help doctors personalize catheter ablation for people with persistent atrial fibrillation (AF). The standard approach isolates the pulmonary veins, but this study adds up to three extra targets based on where the heart shows stable high-rate activity. Researchers will compare outcomes with historical data to see if the personalized approach improves AF termination and reduces recurrence. Forty-five participants will be followed for two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- catheter ablation guided by non-invasive global mapping
- What this could lead to
- If successful, this approach could make atrial fibrillation ablation more effective by targeting the specific sources of the arrhythmia in each patient.
- What could go wrong
- This is a small pilot study with only 45 participants, so results may not apply to everyone. The procedure still carries standard risks of catheter ablation, such as bleeding or heart damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Central Lisbon University Hospital Centre (CHULC), Hospital de Santa Marta
NOT_YET_RECRUITINGLisbon, 1169-024, Portugal
-
Frankfurt University Heart and Vascular Center
NOT_YET_RECRUITINGFrankfurt am Main, 60598, Germany
-
German Heart Center of the Charité, Charité University Hospital Berlin
RECRUITINGBerlin, 10117, Germany
-
Gregorio Marañón General University Hospital
NOT_YET_RECRUITINGMadrid, 28007, Spain
-
Hospital Clinic, University of Barcelona
NOT_YET_RECRUITINGBarcelona, 08036, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?